এক্সপোর্ট সম্পূর্ন হয়েছে — 

RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE

Special systems were developed for response assessment of immunooncology drugs. The role and benefits of particular system in assessing the efficacy of different immunotherapy methods are not clear yet. The objective of this study is to compare the responses on ipilimab (IPI) or dendritic cell vacci...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: A. V. Novik, E. V. Yaremenko, E. M. Anokhina, T. L. Nehaeva, A. I. Semenova, D. Kh. Latipova, S. A. Protsenko, I. A. Baldueva
Materialtyp: Artigo
Språk:Russo
Publicerad: Tomsk National Research Medical Center of the Russian Academy of Sciences 2019-09-01
Serie:Sibirskij Onkologičeskij Žurnal
Ämnen:
melanoma
ipilimumab
dendritic cell vaccines
recist 1.1
irrc
response assessment
immunotherapy
Länkar:https://www.siboncoj.ru/jour/article/view/1136
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk